Biden’s SOTU Targets Drug Companies, But Misses Opportunity To Challenge Health Insurers And Pharmacy Benefit Managers Read more
Novartis CEO Narasimhan Suggests Possible Legislative Action To Reverse Inflation Reduction Act’s Impact On Drug Prices: What Can And Can’t Be Done Read more
Freeland says Canada must seize clean economic opportunities in response to U.S. – National | Globalnews.ca Read more
Inflation Reduction Act Favors Biologics Over Small Molecules: In The Long Term, This Could Partly Undermine Bill’s Effort To Contain Costs Read more
As CMS Asks For The Public’s Feedback On Implementing The Inflation Reduction Act, Unresolved Issues Related To Drug Price Negotiations Remain Read more
Inflation Reduction Act Drug Pricing Provisions Aren’t At All Like Price Controls In Europe Read more